Insider Shareholders with Direct Ownership of Supernus Pharmaceuticals, Inc. (SUPN)
This section provides a comprehensive overview of the insiders with direct ownership of Supernus Pharmaceuticals, Inc. (SUPN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SUPERNUS PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jack A. Khattar
President, CEO |
1,148,678 | 661,165 | 953,579 $35.2 Million | 60 |
Dec 27, 2024
Reduced 0.69%
|
|
Charles W Newhall Iii
Director |
48,169 | 13,200 | 130,275 $4.81 Million | 8 |
Nov 11, 2024
Reduced 7.59%
|
|
John M Siebert
Director |
26,990 | 0 | 87,943 $3.25 Million | 4 |
Feb 23, 2024
Added 4.23%
|
|
Tami Tillotson Martin
Sr. V.P., Regulatory Affairs |
36,600 | 38,216 | 86,933 $3.21 Million | 19 |
Feb 23, 2024
Reduced 0.55%
|
|
Gregory S Patrick
Sr. VP Chief Financial Officer |
25,000 | 25,000 | 44,463 $1.64 Million | 6 |
Nov 09, 2020
Reduced 10.11%
|
|
Frederick M. Hudson
Director |
28,169 | 17,815 | 28,395 $1.05 Million | 7 |
Nov 08, 2024
Reduced 23.5%
|
|
Carrolee Barlow
Director |
11,990 | 0 | 17,201 $634,888 | 3 |
Feb 23, 2024
Added 18.43%
|
|
Georges Gemayel
Director |
46,990 | 38,886 | 13,315 $491,456 | 9 |
Nov 08, 2024
Reduced 44.76%
|
|
Padmanabh P. Bhatt
Sr. VP of IP, CSO |
147,000 | 140,264 | 9,679 $357,251 | 36 |
Dec 03, 2024
Reduced 56.84%
|
|
Frank Mottola
SVP, Quality, GMP, Ops, IT |
22,865 | 23,375 | 8,200 $302,662 | 14 |
Nov 07, 2024
Reduced 64.66%
|
|
Timothy C Dec
Senior Vice-President & CFO |
10,500 | 4,723 | 7,190 $265,382 | 10 |
Feb 23, 2024
Reduced 15.45%
|
|
Jonathan Rubin
SVP, Chief Medical Officer |
7,475 | 2,176 | 6,595 $243,421 | 10 |
Dec 27, 2024
Reduced 11.07%
|
|
Stefan K.F. Schwabe
Executive Vice President & CMO |
100,000 | 100,000 | 2,772 $102,314 | 4 |
Dec 21, 2020
Reduced 94.36%
|